Cleared Traditional

K872611 - SOLOS EYESITE CAP SLEEVE

K872611 is an FDA 510(k) clearance for SOLOS EYESITE CAP SLEEVE, manufactured by Solos Ophthalmology. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 35-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1987
Decision
35d
Days
Class 2
Risk

K872611 is an FDA 510(k) clearance for the SOLOS EYESITE CAP SLEEVE. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Solos Ophthalmology (Norcross, US). The FDA issued a Cleared decision on August 10, 1987 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K872611

510(k) Number K872611 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 1987
Decision Date August 10, 1987
Days to Decision 35 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 110d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 316
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K872611.
C-MATE #CMU 1001
K880062 · O.R. Specialties, Inc. · Mar 1988
SOLOS SINGLE USE TITANIUM TIP
K874334 · Solos Ophthalmology · Jan 1988
PART #860065 IA PAK & PART #860060 IA PAK
K871473 · Medical Technical Products · Aug 1987
IN-LINE OPHTHALMIC IRRIGATING SOLUTION FILTERS
K871854 · CooperVision, Inc. · Jul 1987
FRIGITRONICS ACC-1000 CAPSULE CUTTER
K872362 · Frigitronics of Connecticut, Inc. · Jul 1987
SITE PHACOEMULSIFICATION SYSTEM/OPHTHALMIC USE
K871485 · Site Microsurgical Systems, Inc. · Jun 1987